<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Thu, 16 Jul 2026 18:05:13 -0400--><rss version="2.0">
    <channel>
        <title>Vivani Medical, Inc. (VANI) Press Releases</title>
        <link>https://investors.vivani.com/investors/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_4126e3db6def33d543a652545d1b732f/vivanimedical/files/theme/images/logo-sm.png</url>
                <title>Vivani Medical, Inc. Logo</title>
                <link>/investors</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://investors.vivani.com/investors/news-events/press-releases/detail/221/vivani-medical-to-present-at-the-emerging-growth-conference</link>
                <pubDate>Tue, 14 Jul 26 16:03:00 -0400</pubDate>
                <guid>https://investors.vivani.com/investors/news-events/press-releases/detail/221/vivani-medical-to-present-at-the-emerging-growth-conference</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management]]></title>
                <description><![CDATA[]]></description>
                <link>https://investors.vivani.com/investors/news-events/press-releases/detail/220/vivani-medical-enters-into-agreement-with-novo-nordisk-to</link>
                <pubDate>Tue, 07 Jul 26 07:35:00 -0400</pubDate>
                <guid>https://investors.vivani.com/investors/news-events/press-releases/detail/220/vivani-medical-enters-into-agreement-with-novo-nordisk-to</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.]]></title>
                <description><![CDATA[]]></description>
                <link>https://investors.vivani.com/investors/news-events/press-releases/detail/219/vivani-announces-entry-into-merger-agreement-between-wholly</link>
                <pubDate>Thu, 02 Jul 26 08:00:00 -0400</pubDate>
                <guid>https://investors.vivani.com/investors/news-events/press-releases/detail/219/vivani-announces-entry-into-merger-agreement-between-wholly</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker]]></title>
                <description><![CDATA[]]></description>
                <link>https://investors.vivani.com/investors/news-events/press-releases/detail/218/vivani-medical-announces-appointment-of-august-j-moretti</link>
                <pubDate>Fri, 26 Jun 26 07:30:00 -0400</pubDate>
                <guid>https://investors.vivani.com/investors/news-events/press-releases/detail/218/vivani-medical-announces-appointment-of-august-j-moretti</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management]]></title>
                <description><![CDATA[]]></description>
                <link>https://investors.vivani.com/investors/news-events/press-releases/detail/217/vivani-medical-receives-regulatory-approval-for-the</link>
                <pubDate>Thu, 25 Jun 26 07:30:00 -0400</pubDate>
                <guid>https://investors.vivani.com/investors/news-events/press-releases/detail/217/vivani-medical-receives-regulatory-approval-for-the</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention]]></title>
                <description><![CDATA[]]></description>
                <link>https://investors.vivani.com/investors/news-events/press-releases/detail/216/vivani-medical-ceo-adam-mendelsohn-to-present-at-the-2026</link>
                <pubDate>Mon, 22 Jun 26 16:03:00 -0400</pubDate>
                <guid>https://investors.vivani.com/investors/news-events/press-releases/detail/216/vivani-medical-ceo-adam-mendelsohn-to-present-at-the-2026</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://investors.vivani.com/investors/news-events/press-releases/detail/215/vivani-medical-ceo-adam-mendelsohn-to-present-at-the</link>
                <pubDate>Thu, 28 May 26 08:30:00 -0400</pubDate>
                <guid>https://investors.vivani.com/investors/news-events/press-releases/detail/215/vivani-medical-ceo-adam-mendelsohn-to-present-at-the</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update]]></title>
                <description><![CDATA[]]></description>
                <link>https://investors.vivani.com/investors/news-events/press-releases/detail/214/vivani-medical-reports-first-quarter-2026-financial-results</link>
                <pubDate>Wed, 13 May 26 16:05:00 -0400</pubDate>
                <guid>https://investors.vivani.com/investors/news-events/press-releases/detail/214/vivani-medical-reports-first-quarter-2026-financial-results</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update]]></title>
                <description><![CDATA[]]></description>
                <link>https://investors.vivani.com/investors/news-events/press-releases/detail/213/vivani-medical-reports-fourth-quarter-and-full-year-2025</link>
                <pubDate>Thu, 26 Mar 26 16:16:00 -0400</pubDate>
                <guid>https://investors.vivani.com/investors/news-events/press-releases/detail/213/vivani-medical-reports-fourth-quarter-and-full-year-2025</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://investors.vivani.com/investors/news-events/press-releases/detail/212/vivani-subsidiary-cortigent-presents-promising-6-year-early</link>
                <pubDate>Thu, 29 Jan 26 07:30:00 -0500</pubDate>
                <guid>https://investors.vivani.com/investors/news-events/press-releases/detail/212/vivani-subsidiary-cortigent-presents-promising-6-year-early</guid>
                                                                            </item>
            </channel>
</rss>